Search results
Results from the WOW.Com Content Network
The current yield at 3.80% still outperforms the industry, but it mandates further examination as the ex-dividend date is just around the corner. Pfizer's Inc. (NYSE:PFE) Dividend is Depending on ...
Image source: The Motley Fool. Pfizer (NYSE: PFE) Q4 2024 Earnings Call Feb 04, 2025, 10:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
The ex-date or ex-dividend date represents the date on or after which a security is traded without a previously declared dividend or distribution. [1] The opening price on the ex-dividend date, in comparison to the previous closing price, can be expected to decrease by the amount of the dividend, although this change may be obscured by other ...
On July 22, 2020, the U.S. government placed a conditional advance-purchase order of $2 billion with Pfizer to manufacture 100 million doses of a COVID-19 vaccine, with an option for 500 million more, for use in the United States if the vaccine was shown to be safe, effective, licensed, and authorized by the Food and Drug Administration (FDA).
On October 24, 2020, the New York Times asserted that the Trump administration essentially eliminated the role of the program when it closed the office in 2019. [2] NVPO's former Chair, Daniel Salmon, went on to direct the Institute for Vaccine Safety at the Johns Hopkins Bloomberg School of Public Health. [3]
This photo provided by Pfizer in August 2024 shows a packaging for the company's updated COVID vaccine for ages 12 and up, approved by the U.S. Food and Drug Administration on Thursday, Aug. 22, 2024.
The ACIP was established in March 1964 by the US Surgeon General to assist in the prevention and control of communicable diseases, [2] it recommends licensed new vaccines to be incorporated into the routine immunization schedule, recommends vaccine formulations, and reviews older vaccines to consider revising its recommendations.